Hengenix Biotech Revenue and Competitors
Estimated Revenue & Valuation
- Hengenix Biotech's estimated annual revenue is currently $9.1M per year.
- Hengenix Biotech's estimated revenue per employee is $155,000
Employee Data
- Hengenix Biotech has 59 Employees.
- Hengenix Biotech grew their employee count by -6% last year.
Hengenix Biotech's People
| Name | Title | Email/Phone |
|---|
Hengenix Biotech Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Hengenix Biotech?
Hengenix Biotech, Inc., located in Milpitas, CA, focuses on developing and delivering high-quality, innovative, and affordable medicine to patients worldwide to treat a range of chronic and life-threatening diseases with a focus in oncology and autoimmune diseases. Hengenix is affiliated with Shanghai Henlius Biotech, a global biopharmaceutical company established in 2010. Henlius’ diverse pipeline of over 20 innovative monoclonal antibodies (mAb) includes 汉利康® (HLX01, rituximab injection, the first commercially launched biosimilar in China), 汉曲优® (HLX02, trastuzumab injection, Zercepac® in the EU, first Chinese mAb biosimilar approved in both EU and China), 2 products under NDA review, and over 20 clinical studies for 10 products and 8 combination therapies worldwide. Our goal at Hengenix is to accelerate the discovery and development of innovative biologics (such as monoclonal and bispecific antibody) through technical and operational excellence and to build a leading immuno-oncology franchise with a diverse and distinguished product portfolio. We aim to be a globally trusted biotech company dedicated to bringing affordable, innovative treatment to patients with unmet medical needs worldwide. Hengenix: https://hengenix.com/ Henlius: http://www.henlius.com/en/index.html
keywords:N/A
N/A
Total Funding
59
Number of Employees
$9.1M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Milpitas
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $14.8M | 61 | 15% | N/A |
#2 | $15.6M | 63 | 9% | N/A |
#3 | $10.3M | 70 | 1% | N/A |
#4 | $13.4M | 71 | 16% | N/A |
#5 | $1.7M | 72 | 33% | N/A |